SAB Biotherapeutics, Inc. (SABS): Depreciation & Amortization
$2.99M
Year ended 2025-12-31
-1.9%
3-year compound annual growth
+50.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.99M | -36.4% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $4.71M | +28.8% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $3.65M | +15.3% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $3.17M | +112.9% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $1.49M | +288.5% | 2023-04-28, From 2021-01-01 |
| 2020-12-31 | $383.1K | n/a | 2023-04-28, From 2020-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | 2025-12-31 | $2.99M | -36.4% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $7.32M | +1.5% |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | $3.65M | -7.2% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $8.58M | -3.1% |
| Neumora Therapeutics, Inc. (NMRA) | 2025-12-31 | $208.0K | -67.0% |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | $1.47M | -56.9% |
| ImageneBio, Inc. (IMA) | 2025-12-31 | $400.0K | -63.6% |
| Tenaya Therapeutics, Inc. (TNYA) | 2025-12-31 | $8.44M | -0.4% |
| Instil Bio, Inc. (TIL) | 2025-12-31 | $534.0K | -85.2% |
Compare SABS, STRO, CRBU, VXRT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗